‹ All Posts
SFP RESEARCH

24th Apr 2025 · SEBI-Registered Analyst

Thyrocare Tech

Thyrocare Tech Q4 Results (Consolidated): - Net Profit: ₹21.7 Cr, up 22% YoY, up 14% QoQ - Revenue: ₹187 Cr, up 21% YoY, up 13% QoQ - EBITDA: ₹57.7 Cr, up 71% YoY, up 38% QoQ - EBITDA Margin: 30.8% vs 21.9% YoY, 25.15% QoQ

#TechnicalViews#WatchOutFor#StockInNews#EquityResearch#MacroViews
THYROCARE TECHNOLOGIES_Thu 24 Apr '25_06-32-27.png
215 likes·1 comment